• 311529
Product name | B-mSiglec15 MC38 |
---|---|
Catalog number | 311529 |
Strain background | C57BL/6 |
Aliases | Cd33l, Cd33l3, EG620235, SIGLEC-I |
Tissue | Colon |
Disease | Colon carcinoma |
Species | Mouse |
Application | B-mSiglec15 MC38 cells have the capability to establish tumors in vivo |
on this page
The mouse Siglec15 gene was insert into mouse ROSA26 site. Mouse Siglec15 is highly expressed on the surface of B-mSiglec15 MC38 cells.
Gene targeting strategy for B-mSiglec15 MC38.The mouse Siglec15 CDS was insert into mouse ROSA26 site in B-mSiglec15 MC38.
The Siglec15 expression analysis in B-mSiglec15 MC38 cells by flow cytometry. Single cells were collected from wild-type MC38 and B-mSiglec15 MC38 cells, and analyzed by flow cytometry with anti-human and mouse SIGLEC15 antibody(SIGLEC15-5G12, in house). Mouse Siglec15 was exclusively detectable in B-mSiglec15 MC38 cells but not wild-type MC38 cells. The 2-C12 clone of B-mSiglec15 MC38 cells was used for in vivo experiments.
B-mSiglec15 MC38 cells were transplanted into C57BL/6N mice (n=5), and on 28 days post inoculation, certain volumes of tumors as was taken to detect the expression level of the cells. Cells were analyzed by flow cytometry with anti-human and mouse SIGLEC15 antibody (SIGLEC15-5G12, in house). As shown, mouse Siglec15 was highly expressed on the surface of B-mSiglec15 MC38 tumor cells. B-mSiglec15 MC38 can be used for in vivo efficacy validation.
B-mSiglec15 MC38 tumor cells growth of individual mice. B-mSiglec15 MC38 cells (5x105) and wild-type MC38 cells (5x105 ) were subcutaneously implanted into the C57BL/6N mice (female, 5-8 week-old, n=5). As shown in panel, B-mSiglec15 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.